Latest Breaking News On - Marketing authorisation application - Page 8 : vimarsana.com

Anavex Rise 11% On Receiving Approval Of Blarcamesine By CHMP

Anavex Life Sciences Corp. (AVXL) shares went up by 11% on Tuesday following the announcement that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has approved their oral blarcamesine for Alzheimer's disease, making it eligible for submission of a Union Marketing Authorisation application in the EU.

Anavex life sciences corpUnion marketing authorisationCommittee for medicinal products human useEuropean medicines agencyAnavex life sciencesMedicinal productsHuman useMarketing authorisation application

Anavex Life Sciences Corp Receives Agreement from the Committee for Medicinal Products for Human Use for the Submission of A Marketing Authorisation Application of Oral Blarcamesine for Alzheimer s Disease

Anavex Life Sciences Corp. announced that the Committee for Medicinal Products for Human Use within the European Medicines Agency agreed that oral blarcamesine for Alzheimer s disease is eligible.

Union marketing authorisationCommittee for medicinal products human useAnavex life sciences corpEuropean medicines agencyAnavex life sciencesMedicinal productsHuman useMarketing applicationMarketing authorisation application

Syncona portfolio company Autolus presents clinical data updates

Syncona portfolio company Autolus presents clinical data updates

United statesMartin murphyAutolus therapeutics plc nasdaqDrug administrationAmerican society of hematologySyncona limitedEuropean medicines agencyAutolus therapeutics plcBiologics license applicationMarketing authorisation applicationAutolus therapeutics

SpringWorks Therapeutics (SWTX) Announces FDA Approval of OGSIVEO

SpringWorks Therapeutics (SWTX) Announces FDA Approval of OGSIVEO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMemorial sloan kettering cancer centerJeanne whitingSpringworks careconnectionsSaqib islamEuropean medicines agencySpringworks therapeutics incFounder of the desmoid tumor research foundationDrug administrationSpringworks therapeuticsChief executive officerNew york cityNew england journalImportant safety informationExecutive director emeritus

First pill for desmoid tumours approved

First pill for desmoid tumours approved
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Saqib islamRichard pazdurJeppe gustafsson shutterstockOffice of oncologic diseasesOncology centerEuropean medicines agencyDrug administrationJeppe gustafssonSpringworks therapeutic ogsiveoOncologic diseasesDrug evaluationNew england journalChief executive officerSpringworks therapeuticsWorks therapeuticsMarketing authorisation application